The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Solid Biosciences Inc(NASDAQ:SLDB) 
Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expre...
Website: http://www.solidbio.com
Founded: 2013
Full Time Employees: 121
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Solid Biosciences Days Payable Outstanding ttm (DPO)
Solid Biosciences Op Cashflow Per Share ttm
Solid Biosciences Free Cashflow Per Share ttm
Solid Biosciences Cash Per Share ttm
Solid Biosciences P/S ratio ttm
Solid Biosciences (GAAP) P/E ratio ttm
Solid Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.